FMED ETF
Fidelity Disruptive Medicine ETF
NMF is FMED's largest holding at 5.31% of the fund as of Nov 2, 2026. FMED is Fidelity Disruptive Medicine ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | N | Fidelity Securities Lending Cash Central FundFinancials · Capital Markets | 5.31% | 5.3% | 2,719,314 | $2.72M | Financials | Capital Markets |
| 2 | — | Thermo FisherHealth Care · Life Sciences Tools | 4.26% | 9.6% | 3,200 | $2.18M | Health Care | Life Sciences Tools |
| Sector and industry · Pro | ||||||||
| 3 | N | Natera Inc | 4.14% | 13.7% | 5,600 | $2.12M | ||
| 4 | D | Danaher Corp | 4.00% | 17.7% | 9,000 | $2.05M | ||
| 5 | T | 10x Genomics Inc Class A | 3.91% | 21.6% | 32,500 | $2.00M | ||
| 6 | I | Illumina Inc | 3.01% | 24.6% | 6,800 | $1.54M | ||
| 7 | L | Lifestance Health Group Inc | 2.96% | 27.6% | 114,400 | $1.52M | ||
| 8 | D | Sartorius Stedim Biotech | 2.94% | 30.5% | 6,000 | $1.51M | ||
| 9 | — | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | 2.73% | 33.3% | 1,600 | $1.40M | ||
| 10 | R | Revolution Medicines Inc | 2.64% | 35.9% | 7,200 | $1.35M | ||
| 11 | M | Moderna Inc | 2.63% | 38.5% | 6,100 | $1.35M | ||
| 12 | W | West Pharmaceutical Services Inc | 2.47% | 41.0% | 3,100 | $1.26M | ||
| 13 | H | HeartFlow Inc | 2.39% | 43.4% | 22,500 | $1.23M | ||
| 14 | I | Intuitive Surgical Inc | 2.30% | 45.7% | 2,700 | $1.18M | ||
| 15 | K | Kiniksa Pharmaceuticals International PLC Class A | 2.27% | 48.0% | 12,800 | $1.16M | ||
| 16 | G | Guardant Health, Inc | 2.16% | 50.1% | 6,475 | $1.11M | ||
| 17 | K | Kymera Therapeutics Inc | 2.11% | 52.2% | 8,500 | $1.08M | ||
| 18 | — | Ucb SA | 2.00% | 54.2% | 3,300 | $1.03M | ||
| 19 | C | Cogent Biosciences Inc | 1.97% | 56.2% | 34,000 | $1.01M | ||
| 20 | — | Ascendis Pharma A/S | 1.88% | 58.1% | 3,865 | $962.3K | ||
| 21 | P | Vaxcyte Inc | 1.84% | 59.9% | 15,571 | $943.9K | ||
| 22 | V | Veeva Systems Inc Class A | 1.80% | 61.7% | 3,000 | $921.0K | ||
| 23 | R | Repligen Corp | 1.69% | 63.4% | 5,000 | $864.8K | ||
| 24 | I | Insmed Inc | 1.66% | 65.1% | 7,775 | $849.9K | ||
| 25 | — | Roivant Sciences Ltd. Common Shares | 1.63% | 66.7% | 23,350 | $838.0K | ||
| 26 | E | Edwards Lifesciences Corp | 1.60% | 68.3% | 8,800 | $820.7K | ||
| 27 | A | Alnylam Pharmaceuticals Inc. | 1.54% | 69.8% | 5,000 | $790.0K | ||
| 28 | V | Viridian Therapeutics Inc | 1.53% | 71.4% | 31,100 | $786.8K | ||
| 29 | U | Unitedhealth Group Inc | 1.41% | 72.8% | 1,800 | $720.8K | ||
| 30 | A | Amylyx Pharmaceuticals Inc | 1.29% | 74.1% | 23,554 | $660.5K | ||
| 31 | B | BrightSpring Health Services Inc | 1.28% | 75.4% | 9,900 | $656.0K | ||
| 32 | K | Kestra Medical Technologies Ltd | 1.28% | 76.6% | 22,000 | $655.8K | ||
| 33 | T | Twist Bioscience Corp | 1.26% | 77.9% | 5,000 | $645.2K | ||
| 34 | W | Waystar Holding Corp | 1.24% | 79.1% | 22,600 | $636.0K | ||
| 35 | — | Caris Life Sciences Inc | 1.18% | 80.3% | 18,800 | $603.5K | ||
| 36 | V | Veracyte Inc | 1.15% | 81.5% | 12,021 | $589.0K | ||
| 37 | O | Oruka Therapeutics Inc | 1.12% | 82.6% | 6,000 | $572.6K | ||
| 38 | B | Bruker Corp | 1.10% | 83.7% | 10,100 | $562.5K | ||
| 39 | L | Eli Lilly & Co | 1.09% | 84.8% | 395 | $557.3K | ||
| 40 | I | Disc Medicine Inc | 1.06% | 85.8% | 6,926 | $544.5K | ||
| 41 | B | Boston Scientific Corp | 1.05% | 86.9% | 12,185 | $540.0K | ||
| 42 | E | Enliven Therapeutics Inc | 1.04% | 87.9% | 12,000 | $535.6K | ||
| 43 | L | Legend Biotech Corp ADR | 0.99% | 88.9% | 24,000 | $506.4K | ||
| 44 | A | Axsome Therapeutics Inc | 0.97% | 89.9% | 3,652 | $496.7K | ||
| 45 | P | Praxis Precision Medicines Inc | 0.96% | 90.8% | 1,800 | $493.2K | ||
| 46 | R | Relay Therapeutics Inc | 0.93% | 91.8% | 27,500 | $475.2K | ||
| 47 | — | Definium Therapeutics Inc | 0.91% | 92.7% | 14,300 | $464.3K | ||
| 48 | — | IRhythm Holdings Inc | 0.85% | 93.5% | 3,471 | $437.9K | ||
| 49 | M | MBX Biosciences Inc | 0.85% | 94.4% | 8,000 | $435.2K | ||
| 50 | S | Stoke Therapeutics Inc | 0.81% | 95.2% | 15,670 | $414.9K | ||
| More holdings · Pro | ||||||||
FMED ETF All Holdings
FMED holdings total 76 positions. The top 10 holdings account for 35.9% of the fund, led by Fidelity Securities Lending Cash Central Fund at 5.3%, Thermo Fisher at 4.3%, Natera Inc at 4.1%.
FMED portfolio concentration is moderate, with the top 10 representing 35.9% of total assets. The largest sector exposure is Health Care at 87.0%.
FMED sectors provide a detailed breakdown. FMED overlap shows how holdings compare to other funds in your portfolio.
FMED ETF Holdings
76 of 76 holdings
- 1
Fidelity Securities Lending Cash Central Fund
NMFFinancials5.31% - 2
Thermo Fisher
TMOHealth Care4.26% - 3
Natera Inc
NTRAHealth Care4.14% - 4
Danaher Corporation
DHRHealth Care4.00% - 5
10x Genomics Inc Class A
TXGHealth Care3.91% - 6
Illumina Inc
ILMNHealth Care3.01% - 7
Lifestance Health Group Inc
LFSTHealth Care2.96% - 8
Sartorius Stedim Biotech
DIM:PAUnknown2.94% - 9
Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
ARGX:ASHealth Care2.73% - 10
Revolution Medicines Inc
RVMDHealth Care2.64% - 11
Moderna Inc
MRNAHealth Care2.63% - 12
West Pharmaceutical Services Inc
WSTHealth Care2.47% - 13
HeartFlow Inc
HTFLHealth Care2.39% - 14
Intuitive Surgical Inc
ISRGHealth Care2.30% - 15
Kiniksa Pharmaceuticals International PLC Class A
KNSAUnknown2.27% - 16
Guardant Health, Inc
GHHealth Care2.16% - 17
Kymera Therapeutics Inc
KYMRHealth Care2.11% - 18
UCB SA
UCB:BRHealth Care2.00% - 19
Cogent Biosciences Inc
COGTHealth Care1.97% - 20
Ascendis Pharma A/S
ASND:COHealth Care1.88% - 21
Vaxcyte Inc
PCVXHealth Care1.84% - 22
Veeva Systems Inc Class A
VEEVInformation Technology1.80% - 23
Repligen Corp
RGENHealth Care1.69% - 24
Insmed Inc
INSMHealth Care1.66% - 25
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care1.63% - 26
Edwards Lifesciences Corp
EWHealth Care1.60% - 27
Alnylam Pharmaceuticals Inc.
ALNYHealth Care1.54% - 28
Viridian Therapeutics Inc
VRDNHealth Care1.53% - 29
Unitedhealth Group Incorporated
UNHHealth Care1.41% - 30
Amylyx Pharmaceuticals Inc
AMLXHealth Care1.29% - 31
BrightSpring Health Services Inc
BTSGHealth Care1.28% - 32
Kestra Medical Technologies Ltd
KMTS:BMHealth Care1.28% - 33
Twist Bioscience Corp
TWSTHealth Care1.26% - 34
Waystar Holding Corp
WAYInformation Technology1.24% - 35
Caris Life Sciences Inc
CAIHealth Care1.18% - 36
Veracyte Inc
VCYTHealth Care1.15% - 37
Oruka Therapeutics Inc
ORKAHealth Care1.12% - 38
Bruker Corp
BRKRInformation Technology1.10% - 39
Eli Lilly & Co
LLYHealth Care1.09% - 40
Disc Medicine Inc
IRONHealth Care1.06% - 41
Boston Scientific Corp
BSXHealth Care1.05% - 42
Enliven Therapeutics Inc
ELVNHealth Care1.04% - 43
Legend Biotech Corp ADR
LEGNHealth Care0.99% - 44
Axsome Therapeutics Inc
AXSMHealth Care0.97% - 45
Praxis Precision Medicines Inc
PRAXHealth Care0.96% - 46
Relay Therapeutics Inc
RLAYHealth Care0.93% - 47
Definium Therapeutics Inc
DFTX:CAUnknown0.91% - 48
iRhythm Holdings Inc
IRTCHealth Care0.85% - 49
MBX Biosciences Inc
MBXHealth Care0.85% - 50
Stoke Therapeutics Inc
STOKHealth Care0.81% - 51
Dianthus Therapeutics Inc_None_None
DNTHUnknown0.70% - 52
Xenon Pharmaceuticals Inc
XENEHealth Care0.68% - 53
DexCom Inc
DXCMHealth Care0.66% - 54
ZAI Lab Ltd ADR
ZLABHealth Care0.65% - 55
NewAmsterdam Pharma Co NV
NAMS:ASUnknown0.64% - 56
Septerna Inc
SEPNHealth Care0.58% - 57
First Tracks Biotherapeutics Inc
TRAXUnknown0.57% - 58
Braveheart Bio Inc
BRVEUnknown0.53% - 59
Zenas Biopharma Inc
ZBIOHealth Care0.53% - 60
Spyre Therapeutics Inc
SYREHealth Care0.50% - 61
CytomX Therapeutics Inc
CTMXHealth Care0.49% - 62
Pharvaris NV
PHVSHealth Care0.46% - 63
Janux Therapeutics Inc
JANXHealth Care0.40% - 64
CG Oncology Inc
CGONHealth Care0.34% - 65
Fidelity Cash Central Fund
FTBFXFinancials0.32% - 66
Structure Therapeutics Inc Adr
GPCR:SHHealth Care0.32% - 67
Alignment Healthcare
ALHCHealth Care0.30% - 68
Viking Therapeutics Inc
VKTXHealth Care0.28% - 69
Jade Biosciences Inc
JBIOHealth Care0.27% - 70
Eliem Therapeutics Inc
ELYMHealth Care0.27% - 71
Outset Medical, Inc.
OMHealth Care0.27% - 72
Olema Pharmaceuticals Inc
OLMAHealth Care0.21% - 73
Annexon Inc
ANNXHealth Care0.18% - 74
European Monetary Unit
Other0.00% - 75
US Dollar
Other-0.52% - 76
Net Other Assets
Other-4.81%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Fidelity Securities Lending Cash Central Fund | NMF | 5.310% | ||
| 2 | Thermo Fisher | TMO | 4.260% | ||
| 3 | Natera Inc | NTRA | 4.140% | ||
| 4 | Danaher Corporation | DHR | 4.000% | ||
| 5 | 10x Genomics Inc Class A | TXG | 3.910% | ||
| 6 | Illumina Inc | ILMN | 3.010% | ||
| 7 | Lifestance Health Group Inc | LFST | 2.960% | ||
| 8 | Sartorius Stedim Biotech | DIM:PA | 2.940% | ||
| 9 | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | ARGX:AS | 2.730% | ||
| 10 | Revolution Medicines Inc | RVMD | 2.640% | ||
| 11 | Moderna Inc | MRNA | 2.630% | ||
| 12 | West Pharmaceutical Services Inc | WST | 2.470% | ||
| 13 | HeartFlow Inc | HTFL | 2.390% | ||
| 14 | Intuitive Surgical Inc | ISRG | 2.300% | ||
| 15 | Kiniksa Pharmaceuticals International PLC Class A | KNSA | 2.270% | ||
| 16 | Guardant Health, Inc | GH | 2.160% | ||
| 17 | Kymera Therapeutics Inc | KYMR | 2.110% | ||
| 18 | UCB SA | UCB:BR | 2.000% | ||
| 19 | Cogent Biosciences Inc | COGT | 1.970% | ||
| 20 | Ascendis Pharma A/S | ASND:CO | 1.880% | ||
| 21 | Vaxcyte Inc | PCVX | 1.840% | ||
| 22 | Veeva Systems Inc Class A | VEEV | 1.800% | ||
| 23 | Repligen Corp | RGEN | 1.690% | ||
| 24 | Insmed Inc | INSM | 1.660% | ||
| 25 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 1.630% | ||
| 26 | Edwards Lifesciences Corp | EW | 1.600% | ||
| 27 | Alnylam Pharmaceuticals Inc. | ALNY | 1.540% | ||
| 28 | Viridian Therapeutics Inc | VRDN | 1.530% | ||
| 29 | Unitedhealth Group Incorporated | UNH | 1.410% | ||
| 30 | Amylyx Pharmaceuticals Inc | AMLX | 1.290% | ||
| 31 | BrightSpring Health Services Inc | BTSG | 1.280% | ||
| 32 | Kestra Medical Technologies Ltd | KMTS:BM | 1.280% | ||
| 33 | Twist Bioscience Corp | TWST | 1.260% | ||
| 34 | Waystar Holding Corp | WAY | 1.240% | ||
| 35 | Caris Life Sciences Inc | CAI | 1.180% | ||
| 36 | Veracyte Inc | VCYT | 1.150% | ||
| 37 | Oruka Therapeutics Inc | ORKA | 1.120% | ||
| 38 | Bruker Corp | BRKR | 1.100% | ||
| 39 | Eli Lilly & Co | LLY | 1.090% | ||
| 40 | Disc Medicine Inc | IRON | 1.060% | ||
| 41 | Boston Scientific Corp | BSX | 1.050% | ||
| 42 | Enliven Therapeutics Inc | ELVN | 1.040% | ||
| 43 | Legend Biotech Corp ADR | LEGN | 0.990% | ||
| 44 | Axsome Therapeutics Inc | AXSM | 0.970% | ||
| 45 | Praxis Precision Medicines Inc | PRAX | 0.960% | ||
| 46 | Relay Therapeutics Inc | RLAY | 0.930% | ||
| 47 | Definium Therapeutics Inc | DFTX:CA | 0.910% | ||
| 48 | iRhythm Holdings Inc | IRTC | 0.850% | ||
| 49 | MBX Biosciences Inc | MBX | 0.850% | ||
| 50 | Stoke Therapeutics Inc | STOK | 0.810% | ||
| 51 | Dianthus Therapeutics Inc_None_None | DNTH | 0.700% | ||
| 52 | Xenon Pharmaceuticals Inc | XENE | 0.680% | ||
| 53 | DexCom Inc | DXCM | 0.660% | ||
| 54 | ZAI Lab Ltd ADR | ZLAB | 0.650% | ||
| 55 | NewAmsterdam Pharma Co NV | NAMS:AS | 0.640% | ||
| 56 | Septerna Inc | SEPN | 0.580% | ||
| 57 | First Tracks Biotherapeutics Inc | TRAX | 0.570% | ||
| 58 | Braveheart Bio Inc | BRVE | 0.530% | ||
| 59 | Zenas Biopharma Inc | ZBIO | 0.530% | ||
| 60 | Spyre Therapeutics Inc | SYRE | 0.500% | ||
| 61 | CytomX Therapeutics Inc | CTMX | 0.490% | ||
| 62 | Pharvaris NV | PHVS | 0.460% | ||
| 63 | Janux Therapeutics Inc | JANX | 0.400% | ||
| 64 | CG Oncology Inc | CGON | 0.340% | ||
| 65 | Fidelity Cash Central Fund | FTBFX | 0.320% | ||
| 66 | Structure Therapeutics Inc Adr | GPCR:SH | 0.320% | ||
| 67 | Alignment Healthcare | ALHC | 0.300% | ||
| 68 | Viking Therapeutics Inc | VKTX | 0.280% | ||
| 69 | Jade Biosciences Inc | JBIO | 0.270% | ||
| 70 | Eliem Therapeutics Inc | ELYM | 0.270% | ||
| 71 | Outset Medical, Inc. | OM | 0.270% | ||
| 72 | Olema Pharmaceuticals Inc | OLMA | 0.210% | ||
| 73 | Annexon Inc | ANNX | 0.180% | ||
| 74 | European Monetary Unit | - | 0.000% | ||
| 75 | US Dollar | - | -0.520% | ||
| 76 | Net Other Assets | - | -4.810% |









































